IL118488A - The irregular crystalline form of anhydric acid 7 -)] A6, A5, A1 [- 6 Amino - 3 - Azbitsklo] 0.1.3 [Hex - 3 - yl (- 6 - Fluoro - 1 -) 2, 4 -Depluoroprop - Google Patents

The irregular crystalline form of anhydric acid 7 -)] A6, A5, A1 [- 6 Amino - 3 - Azbitsklo] 0.1.3 [Hex - 3 - yl (- 6 - Fluoro - 1 -) 2, 4 -Depluoroprop

Info

Publication number
IL118488A
IL118488A IL11848896A IL11848896A IL118488A IL 118488 A IL118488 A IL 118488A IL 11848896 A IL11848896 A IL 11848896A IL 11848896 A IL11848896 A IL 11848896A IL 118488 A IL118488 A IL 118488A
Authority
IL
Israel
Prior art keywords
oxo
fluoro
hex
amino
azabicyclo
Prior art date
Application number
IL11848896A
Other languages
English (en)
Hebrew (he)
Other versions
IL118488A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL118488A0 publication Critical patent/IL118488A0/xx
Publication of IL118488A publication Critical patent/IL118488A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL11848896A 1995-06-06 1996-05-30 The irregular crystalline form of anhydric acid 7 -)] A6, A5, A1 [- 6 Amino - 3 - Azbitsklo] 0.1.3 [Hex - 3 - yl (- 6 - Fluoro - 1 -) 2, 4 -Depluoroprop IL118488A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1995/007211 WO1996039406A1 (en) 1995-06-06 1995-06-06 NOVEL CRYSTAL FORM OF ANHYDROUS 7-([1α, 5α, 6α]-6-AMINO-3-AZABICYCLO[3.1.0]HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, METHANESULFONIC ACID SALT

Publications (2)

Publication Number Publication Date
IL118488A0 IL118488A0 (en) 1996-09-12
IL118488A true IL118488A (en) 1999-01-26

Family

ID=39431076

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11848896A IL118488A (en) 1995-06-06 1996-05-30 The irregular crystalline form of anhydric acid 7 -)] A6, A5, A1 [- 6 Amino - 3 - Azbitsklo] 0.1.3 [Hex - 3 - yl (- 6 - Fluoro - 1 -) 2, 4 -Depluoroprop

Country Status (38)

Country Link
US (1) US5763454A (sl)
EP (1) EP0789697B1 (sl)
JP (1) JP3145715B2 (sl)
KR (1) KR100191989B1 (sl)
CN (1) CN1055474C (sl)
AR (1) AR002753A1 (sl)
AU (1) AU703634B2 (sl)
BG (1) BG62443B1 (sl)
BR (1) BR9602630A (sl)
CA (1) CA2223404C (sl)
CZ (1) CZ285878B6 (sl)
DE (1) DE69503066T2 (sl)
DK (1) DK0789697T3 (sl)
DZ (1) DZ2046A1 (sl)
ES (1) ES2117426T3 (sl)
FI (1) FI974441A0 (sl)
HR (1) HRP960267B1 (sl)
HU (1) HUP9601540A3 (sl)
IL (1) IL118488A (sl)
IS (1) IS4351A (sl)
LV (1) LV11619B (sl)
MA (1) MA23892A1 (sl)
NO (1) NO305599B1 (sl)
NZ (1) NZ286735A (sl)
OA (1) OA10293A (sl)
PE (1) PE38097A1 (sl)
PL (1) PL314604A1 (sl)
RU (1) RU2125571C1 (sl)
SG (1) SG54339A1 (sl)
SI (1) SI9600185A (sl)
SK (1) SK280535B6 (sl)
TN (1) TNSN96084A1 (sl)
TW (2) TW580389B (sl)
UA (1) UA44718C2 (sl)
UY (1) UY25459A1 (sl)
WO (1) WO1996039406A1 (sl)
YU (1) YU34596A (sl)
ZA (1) ZA964647B (sl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020032216A1 (en) 1997-03-21 2002-03-14 Lg Chemical Ltd. Salt of naphthyridine carboxylic acid derivative
MA24500A1 (fr) 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .
HN1998000106A (es) 1997-08-01 1999-01-08 Pfizer Prod Inc Composiciones parenterales de alatroflaxacino
DE19800214A1 (de) 1998-01-06 1999-07-15 Knoll Ag Verfahren zur Herstellung von Doxazosin-Mcsylat in einer als Form A bezeichneten Kristallmodifikation und ein Zwischenprodukt dafür
US7019142B2 (en) * 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
GB9818258D0 (en) * 1998-08-21 1998-10-14 Pfizer Ltd Antifungal compositions
HN1999000141A (es) * 1998-09-03 2000-06-19 Pfizer Prod Inc Procedimiento para preparar sales de trovafloxacina de adicion de acidos.
GB9820405D0 (en) * 1998-09-18 1998-11-11 Smithkline Beecham Plc Process
ES2164520B1 (es) 1999-03-16 2003-04-01 Medichem Sa "procedimiento de obtencion del polimorfo a del mesilato de doxazosina"
US6239141B1 (en) 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
US6660864B2 (en) 2001-06-29 2003-12-09 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6596871B2 (en) 2001-06-29 2003-07-22 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetraol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6573382B2 (en) 2001-06-29 2003-06-03 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6657061B2 (en) 2001-06-29 2003-12-02 Grayson Walker Stowell Polymorphic forms of 6-[4-1(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6388080B1 (en) 2001-06-29 2002-05-14 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
US6531603B1 (en) 2001-06-29 2003-03-11 Grayson Walker Stowell Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
KR100517638B1 (ko) 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법
CN102512364A (zh) * 2011-12-30 2012-06-27 天津市嵩锐医药科技有限公司 一种供注射用的甲磺酸阿拉曲伐沙星药物组合物
TWI608970B (zh) * 2013-01-11 2017-12-21 參天製藥股份有限公司 內塞和具備該內塞的液體收容容器、以及注口的前端構造和具備該構造的液體收容容器

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991002526A1 (en) * 1989-08-16 1991-03-07 Pfizer Inc. Azabicyclo quinolone carboxylic acids
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
CN1141634A (zh) * 1994-01-18 1997-01-29 辉瑞大药厂 萘啶酮羧酸盐的制备方法和中间体
GB2289674A (en) * 1994-05-23 1995-11-29 Pfizer Antibacterial naphthyridine

Also Published As

Publication number Publication date
YU34596A (sh) 1999-03-04
AU5474996A (en) 1996-12-19
ZA964647B (en) 1997-10-22
MX9709873A (es) 1998-03-31
PE38097A1 (es) 1997-10-10
CZ285878B6 (cs) 1999-11-17
DK0789697T3 (da) 1998-10-19
CZ162596A3 (cs) 1998-09-16
CN1055474C (zh) 2000-08-16
EP0789697B1 (en) 1998-06-17
HUP9601540A2 (en) 1997-02-28
DZ2046A1 (fr) 2002-10-22
WO1996039406A1 (en) 1996-12-12
HRP960267A2 (en) 1997-08-31
LV11619A (lv) 1996-12-20
SK280535B6 (sk) 2000-03-13
NO962321D0 (no) 1996-06-05
SI9600185A (en) 1997-04-30
IL118488A0 (en) 1996-09-12
BG100639A (bg) 1997-02-28
DE69503066T2 (de) 1998-10-15
MA23892A1 (fr) 1996-12-31
TW403751B (en) 2000-09-01
UA44718C2 (uk) 2002-03-15
OA10293A (en) 1997-09-19
US5763454A (en) 1998-06-09
LV11619B (en) 1997-04-20
CA2223404A1 (en) 1996-12-12
SK71996A3 (en) 1997-03-05
FI974441A (fi) 1997-12-05
CA2223404C (en) 2001-01-16
NO305599B1 (no) 1999-06-28
RU2125571C1 (ru) 1999-01-27
BR9602630A (pt) 1998-09-08
ES2117426T3 (es) 1998-08-01
SG54339A1 (en) 1998-11-16
UY25459A1 (es) 1999-11-17
TNSN96084A1 (fr) 2005-03-15
JPH10506650A (ja) 1998-06-30
TW580389B (en) 2004-03-21
KR970001352A (ko) 1997-01-24
FI974441A0 (fi) 1997-12-05
NO962321L (no) 1996-12-09
CN1148596A (zh) 1997-04-30
HUP9601540A3 (en) 1997-05-28
HRP960267B1 (en) 2000-06-30
PL314604A1 (en) 1996-12-09
IS4351A (is) 1996-12-07
EP0789697A1 (en) 1997-08-20
DE69503066D1 (de) 1998-07-23
KR100191989B1 (ko) 1999-06-15
AU703634B2 (en) 1999-03-25
NZ286735A (en) 1998-01-26
HU9601540D0 (en) 1996-07-29
AR002753A1 (es) 1998-04-29
BG62443B1 (bg) 1999-11-30
JP3145715B2 (ja) 2001-03-12

Similar Documents

Publication Publication Date Title
EP0789697B1 (en) CRYSTAL FORM OF ANHYDROUS 7-((1a,5a, 6a)-6-AMINO-3-AZABICYCLO ( 3.1. 0]HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, METHANESULFONIC ACID SALT
TWI423976B (zh) 適合作為傑納斯激酶（ｊａｎｕｓ ｋｉｎａｓｅ）抑制劑之氮雜吲哚
JP3463928B2 (ja) アラトロフロキサシン非経口組成物
AU704115B2 (en) Zwitterionic forms of trovafloxacin
AP788A (en) Novel crystal form of anhydrous 7-(1a, 5a, 6a)-6-Amino-3-Azabicyclo(3.1.0) hex-3-YI)-6-Fluoro-1-(2,4- Difluorophenyl)-1,4-Dihydro-4-Oxo-1, 8-Naphthyridine-3-Carboxylic Acid, Methanesulfonic acid salt.
EP0847400B1 (en) Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin
EP0523013B1 (en) Use of benzimidazoline-2-oxo-1-carboxylic acid derivatives in the treatment of organic mental diseases
JP2003532625A (ja) ストレプトグラミン誘導体、それらの製造およびそれらを含有する組成物
JPS62267228A (ja) 抗菌剤
MXPA98001664A (en) Zwitterionic forms of trovafloxacin, procedure for its preparation, compositions that contain them and use of the mis

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees